T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy-Reference-Cited by-同舟云学术

T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy

Published:2013-04-01 Issue:17 Volume:110 Page:6973-6978
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Zhong S.,Malecek K.,Johnson L. A.,Yu Z.,Vega-Saenz de Miera E.,Darvishian F.,McGary K.,Huang K.,Boyer J.,Corse E.,Shao Y.,Rosenberg S. A.,Restifo N. P.,Osman I.,Krogsgaard M.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference63 articles.

1. Engineering lymphocyte subsets: tools, trials and tribulations

2. Adoptive cell transfer: a clinical path to effective cancer immunotherapy

3. White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy

4. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

5. Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review;European Journal of Cancer;2024-09

2. Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding;Journal of Biological Chemistry;2024-09

3. Frontiers and challenges of immune cell therapy research in solid tumors;Chinese Science Bulletin;2024-08-20

4. Development and validation of a novel disulfidptosis-related lncRNAs signature in patients with HPV-negative oral squamous cell carcinoma;Scientific Reports;2024-06-23

5. SwiftTCR: Efficient computational docking protocol of TCRpMHC-I complexes using restricted rotation matrices;2024-06-01